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Dstrategy.27 Immediate postoperative management is comple-
mentary, with emphasis on minimizing both volume admin-
istration and excessive sedation. Long-term anticoagulation
management is typically with aspirin alone. Other medical
management includes furosemide and afterload reduction,
as indicated.
In summary, we present our experience with highly selec-
tive use of fenestration during Fontan palliation. The data
support a nonfenestrated, extracardiac conduit technique
for Fontan palliation, irrespective of anatomic subtype,
with fenestration reserved for only the patients at highest
risk. Relying on improvements in all areas of medical and
surgical management, this strategy results in equal or better
surgical outcomes and fewer reinterventions. Further longi-
tudinal follow-up of this patient population, including func-
tional outcomes, will benefit the assessment of this approach
for patients with single-ventricle anatomy.
We thank all our team members at Texas Children’s Hospital for
their tireless dedication to and care of these patients. Without them,
these results for our patients undergoing Fontan palliation would
not be possible.References
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Dr Scott M. Bradley (Charleston, SC). You have nicely traced
the evolution of your group’s strategy through the last 7 years to
one that now includes use of an extracardiac conduit, with the
use of CPB, minimal use of aortic crossclamping, and decreasing
in use of fenestrations (only 6% of patients in the last year). You
have shown without question that this strategy can be used with
good outcomes, looking at all the usual outcome measures that
are examined for Fontan procedures. Both the use of this strategy
and your outcomes are in line with what has been described in pre-
vious publications, for example, those from the Stanford/University
of California San Francisco experience and from the Los Angeles
Children’s Hospital experience.
I have several questions. The first has to do with the duration of
pleural effusion drainage in your study, which ran about 6 days.
This was discussed in the debate yesterday, but there is certainly
a great deal of variation in the literature; some of this variation is
undoubtedly related to differences in management protocols for
chest tubes after Fontan procedures. Could you elaborate on your
group’s approach to postoperative management of chest tubes?
Specifically, when do you decide to remove chest tubes? Do you
have any consistent approach to the use of medications to try to
cut down on effusion drainage, such as angiotensin-converting en-
zyme inhibitors and diuretics?ery c July 2010
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DDr Salazar.Our strategy for decreasing chest tube output begins
with aggressive ultrafiltration in the operating room, minimization
of fluid administration in the postoperative period, and a policy of
early extubation. With regard to timing of chest tube removal, all of
us at Texas Children’s Hospital are conservative and prefer to leave
the tubes in until minimal output has been demonstrated. Diuretic
administration is routine, preferring to see a mild increase in blood
urea nitrogen as a result of our diuretic management. Furthermore,
patients are fluid restricted to half or three-quarters maintenance to-
tal fluid intake for at least the first week after surgery.
Dr Bradley. Do you have any specific amount of chest
tube drainage that you use to decidewhen to take the chest tubes out?
Dr Salazar. I prefer to tailor that decision to the specific patient,
taking into account the clinical situation. As a general rule, we do
not remove drains until output has decreased below 1 mL/(kg $ d).
Dr Bradley. It appeared that approximately a quarter of your pa-
tients were readmitted. I assume that some of these were for treat-
ment of effusions?
Dr Salazar. Correct. Readmission was defined as occurring any
time within 1 month of discharge, to capture late readmissions.
More than half of those readmissions were for pleural effusion
management. Interestingly, the percentages of patients requiring re-
admission for effusion in the fenestrated and nonfenestrated groups
were equivalent.
Dr Bradley. If you were to include that period in the duration of
pleural effusion drainage and the stay data, both of those pieces of
information would probably look a bit different. That may be some-
thing you would want to consider putting in the article.
You now fenestrate very selectively. How do you decide in
which cases to fenestrate? Do you decide preoperatively or in the
operating room, and what specific criteria do you look at?
Dr Salazar. The decision to fenestrate is a clinical judgment
made in the operating room. Patients known to be at higher risk,
such as those receiving single-lung Fontan palliation, those with se-
vere atrioventricular valve regurgitation, and those with high pul-
monary vascular resistance are most likely to have fenestration.
The conduct of the operation also influences the fenestration de-
cision. If a significant period of cardiac arrest or even circulatory
arrest is required (although this is rare), then fenestration is more
likely. Fenestration is used to improve the early outcomes after
the Fontan operation. If preoperative and intraoperative variables
suggest a risk compromising the patient’s early postoperative
course, then we would fenestrate. Ultimately, it is a clinical judg-
ment that is based on the experience that fenestration is usually
not necessary.
Dr Bradley. So it sounds like a general gestalt of the patient’s
characteristics and how things are going in the operating room,
as opposed to specific hemodynamic criteria?
Dr Salazar. Ultimately, I agree.
Dr Bradley. Fair enough. Finally, I think it’s a bit more difficult
to fenestrate reliably extracardiac conduits than intra-atrial lateral
tunnels. Can you comment on your group’s technique?
Dr Salazar. Our technique is to fenestrate extracardiac con-
duits with the heart beating. We use a partial occlusion clamp
on the GORE-TEX conduit and atrium. An aortic punch is
used for the GORE-TEX conduit fenestration, although the depth
of sutures on the atrial side can influence the effective size of the
fenestration.The Journal of Thoracic and CaDr Bradley. So it’s side-to-side between the atrium and the out-
side of the GORE-TEX graft, as opposed to using a second tube
graft between the two?
Dr Salazar. That’s correct.
Dr Bradley. I think you have some information in your article
about the reliability of fenestration, specifically looking at postop-
erative systemic oxygen saturation. Can you just comment on the
postoperative oxygen saturation difference between the patients
with and without fenestration?
Dr Salazar.Most of the patients with fenestrated Fontan proce-
dures underwent the lateral tunnel technique. The lateral tunnel baf-
fle was fenestrated with an aortic punch, typically ranging in size
from 3 to 4 mm.
Interestingly, the discharge oxygen saturations were similar in
the patients with and without fenestration. This may reflect a less
ill patient population referred for Fontan palliation relative to 10
years ago. Decreasing preoperative transpulmonary gradients and
pulmonary vascular resistance, coupled with operations that mini-
mize the negative physiologic impact of surgery, have likely led
to less shunting across the fenestration.
Dr Bradley. So the numbers were, say, 92% versus 94%?
Dr Salazar. Average discharge saturations were 91% with fen-
estration and 93% without fenestration.
Dr Francois Lacour-Gayet (Aurora, Colo). I enjoyed your pre-
sentation. I understand that the rule now is no fenestration. Do you
believe that there is an exception for altitude? In Denver, we fenes-
trate all our Fontan procedures and would not dare not to fenestrate.
Can you elaborate on this and perhaps give us a limit, an altitude at
which you would consider not to fenestrate?
Dr Salazar. I appreciate your question, Dr Lacour-Gayet. Not
having lived or operated in Denver, I won’t presume to make
a general recommendation for the city. Having said this, the de-
creased partial pressure of oxygen at altitude likely translates into
some increase in pulmonary vascular resistance and reactivity. I
would proceed cautiously and base recommendations on clinical
experience.
Dr James S. Tweddell (Milwaukee, Wis). You were talking
about aggressive use of diuretics. What specific diuretics are you
using?
Dr Salazar.Most of the time, we use furosemide alone for post-
operative diuresis. Our dose typically is 1 mg/kg, administered 2 or
3 times a day. Some may not consider that aggressive, but that is
what I’m talking about.
Dr Tweddell.Did you ever consider using spironolactone in ad-
dition?
Dr Salazar.We have used spironolactone in addition to furose-
mide for those few patients with prolonged chest tube drainage.
Dr Frank L. Hanley (Stanford, Calif).When you do your side-
to-side fenestration with the punch and then you put the atrium
against that hole, do you put your sutures directly into the edge
of the punch when you’re actually making the surgical connection?
Dr Salazar. You mean to the inside?
Dr Hanley. When you’re bringing the atrium to the GORE-
TEX—I presume you use GORE-TEX?
Dr Salazar. Yes.
Dr Hanley. Are the sutures that go through the GORE-TEX go-
ing through the edge of the hole? I mean, are the sutures going into
the actual hole of the 4-mm punch?rdiovascular Surgery c Volume 140, Number 1 135
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DDr Salazar.Yes, I typically take thin bites of atrium and GORE-
TEX to avoid compromising the effective size of the fenestration.
Dr Hanley. If I could just make a suggestion?
Dr Salazar. Please do.
Dr Hanley. We used to do that, too. When you do that, if you
pick up too much of the atrium or the atrium is bulky, which is
not uncommon in a single ventricle, you will get a tunnel effect
to the fenestration because the atrial tissues impinge on the punch
hole, making the size of the hole unreliable.We prefer to put a large,
side-biting clamp on the GORE-TEX tube and then make the 4-mm
punch inside the relatively large surface area of GORE-TEX
sequestered by the clamp. We put another large, side-biting clamp
on the atrium, sequestering a relatively large surface area of atrium
as well. Then we make a long atriotomy, maybe 2 cm, and sew the
cut edge of the atrium onto the sequestered surface of the GORE-
TEX graft, at least half a centimeter if not more away from the136 The Journal of Thoracic and Cardiovascular Surgedge of the punch hole, onto the flat surface of the GORE-TEX.
So in the end, if you were sitting in the atrium and looking at that
atrial incision, you would see a 1.5-cm circle or oval of GORE-
TEX with a 4-mm punch in the middle of it. It is an undistorted
true 2-dimensional fenestration.
Dr Salazar. You have not had any problems with clots forming
in that area?
Dr Hanley. Not to our knowledge.
Dr Tweddell. I would just say that we use exactly the same tech-
nique. And actually I use the inferior vena cava, or the atrial end of
the inferior vena cava. You can use that to sew around the fenestra-
tion, just as Dr Hanley suggested, and we have not seen any conse-
quences. It gives you a reliable fenestration.
Dr Salazar. Thank you, and your point is well taken. The good
news is that, excepting the possibilities at high altitude, fenestration
of extracardiac conduits is rarely necessary.ery c July 2010
